Search research articles
Contact Us
Filters
Showing results (131-140 of 170) with videos related to
Page
of 17
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2019
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of <sup>177</sup>Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet, Shahneen Sandhu, Amir Iravani, et al.
European Urology
|
December 26, 2021
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT Trial
Shankar Siva, Mathias Bressel, Simon T Wood, et al.
Clinical Colorectal Cancer
|
March 18, 2021
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors
Koji Ando, Al Ozonoff, Shin-Yin Lee, et al.
Investigational New Drugs
|
May 7, 2013
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)
Suzanne Richter, Philippe L Bedard, Eric Xueyu Chen, et al.
The Journal of Urology
|
December 27, 2022
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura, Vishal Navani, Matthew S Ernst, et al.
JCO Precision Oncology
|
August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery
Kortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
The New England Journal of Medicine
|
May 14, 2015
Randomized trial of TAS-102 for refractory metastatic colorectal cancer
Robert J Mayer, Eric Van Cutsem, Alfredo Falcone, et al.
BJU International
|
March 31, 2022
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres
Elizabeth A Connolly, Andrew Weickhardt, Peter Grimison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2025
Prognostic Value of Initial Imaging and PSA Change with [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A ProsTIC Registry Analysis
David C Chen, James P Buteau, Nathan Papa, et al.
Clinical Genitourinary Cancer
|
January 8, 2026
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)
Audreylie Lemelin, Martin Zarba, Kosuke Takemura, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 170) with videos related to
Sort By:
Page
of 17
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2019
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of <sup>177</sup>Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet, Shahneen Sandhu, Amir Iravani, et al.
European Urology
|
December 26, 2021
Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma-The RAPPORT Trial
Shankar Siva, Mathias Bressel, Simon T Wood, et al.
Clinical Colorectal Cancer
|
March 18, 2021
Multicohort Retrospective Validation of a Predictive Biomarker for Topoisomerase I Inhibitors
Koji Ando, Al Ozonoff, Shin-Yin Lee, et al.
Investigational New Drugs
|
May 7, 2013
A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575)
Suzanne Richter, Philippe L Bedard, Eric Xueyu Chen, et al.
The Journal of Urology
|
December 27, 2022
Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
Kosuke Takemura, Vishal Navani, Matthew S Ernst, et al.
JCO Precision Oncology
|
August 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery
Kortnye Smith, Sophie O'Haire, Benjamin Markman, et al.
The New England Journal of Medicine
|
May 14, 2015
Randomized trial of TAS-102 for refractory metastatic colorectal cancer
Robert J Mayer, Eric Van Cutsem, Alfredo Falcone, et al.
BJU International
|
March 31, 2022
High-dose chemotherapy for relapsed germ cell tumours: outcomes in low-volume specialized centres
Elizabeth A Connolly, Andrew Weickhardt, Peter Grimison, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 9, 2025
Prognostic Value of Initial Imaging and PSA Change with [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A ProsTIC Registry Analysis
David C Chen, James P Buteau, Nathan Papa, et al.
Clinical Genitourinary Cancer
|
January 8, 2026
Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC)
Audreylie Lemelin, Martin Zarba, Kosuke Takemura, et al.
Page
of 17